Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/article/10.1007/s11239-018-1617-2/fulltext.html
Reference42 articles.
1. Chai-Adisaksopha C, Hillis C, Isayama T, Lim W, Iorio A, Crowther M (2015) Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost 13(11):2012–2020
2. Weitz JI (2016) Factor XI and factor XII as targets for new anticoagulants. Thromb Res 141(Suppl 2):S40–S45
3. Sartori MT, Prandoni P (2016) How to effectively manage the event of bleeding complications when using anticoagulants. Expert Rev Hematol 9(1):37–50
4. Levy JH (2016) Discontinuation and management of direct-acting anticoagulants for emergency procedures. Am J Emerg Med 34(11S):14–18
5. Jones D (2015) Anticoagulant antidotes start yielding Phase III promise. Nat Rev Drug Discov 14:5–6
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Andexanet alpha versus four-factor prothrombin complex concentrate in DOACs anticoagulation reversal: an updated systematic review and meta-analysis;Critical Care;2024-07-05
2. Andexanet alfa therapy showed No increased rate of thromboembolic events in spontaneous intracranial hemorrhage patients: A multicenter electronic health record study;World Neurosurgery: X;2024-07
3. Assessment of the hypoglycemic and anti-hemostasis effects of Paederia foetida (L.) in controlling diabetes and thrombophilia combining in vivo and computational analysis;Computational Biology and Chemistry;2023-12
4. Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance;Cureus;2023-08-23
5. Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model;Thrombosis and Haemostasis;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3